Bladder EpiCheck clinical utility to predict BCG response in non-muscle-invasive bladder cancer. Roldan FL, Ingelmo-Torres M, Mercader C, Figueras M, et al. BJU Int 2025 Mar 6. doi: 10.1111/bju.16697.

Read + Share

Amedeo Smart

Independent Medical Education

Roldan FL, Ingelmo-Torres M, Mercader C, Figueras M, et al. Bladder EpiCheck clinical utility to predict BCG response in non-muscle-invasive bladder cancer. BJU Int 2025 Mar 6. doi: 10.1111/bju.16697.
PMID: 40047306